Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NeoGenomics Inc. Common Stock (NEO) vs abrdn Physical Palladium Shares ETF (PALL) Price & Performance

NeoGenomics Inc. Common StockTrade
abrdn Physical Palladium Shares ETFTrade

Price performance (Past 24H)

Key statistics

NeoGenomics Inc. Common Stock vs abrdn Physical Palladium Shares ETF — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B), while abrdn Physical Palladium Shares ETF trades at $20.5 (market cap $602.28M). The key difference: NeoGenomics Inc. Common Stock is far larger — about 3.6× abrdn Physical Palladium Shares ETF's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, abrdn Physical Palladium Shares ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and abrdn Physical Palladium Shares ETF for 34 Days on average.

NEOPALL
Market Cap
$2.14B$602.28M
Volume
2,228,400980,533
Sector
HealthCommodities - Metals/Agriculture
52-Week High
$19.91$37.18
52-Week Low
$7.19$19.83
Typical Hold Time
0 Days34 Days
Enterprise Value
$2.44B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NeoGenomics Inc. Common Stock

No Aura AI signal available yet.

abrdn Physical Palladium Shares ETF

PALL trades at $20.38, down 1.12% with a bearish technical signal from moving averages. The ETF shows oversold conditions with RSI readings below 30, while palladium prices remain 47% below January 2026 highs. Recent news highlights potential catch-up opportunities as platinum and palladium have lagged the broader precious metals rally.

The outlook suggests contrarian opportunity as palladium approaches technical support levels, though fundamental data remains limited. Key risks include continued commodity price pressure and industrial demand uncertainty, while potential catalysts include supply constraints and renewed institutional interest in undervalued precious metals.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NEO
100% Buy0% Sell
Avg holding period · 0 Days
PALL
100% Buy0% Sell
Avg holding period · 34 Days

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →

About abrdn Physical Palladium Shares ETF

PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.

Read more on PALL →